Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Austin Chen

Showing results (41-50 of 56) with videos related to

Pageof 6
Sort By:
Bioorganic & Medicinal Chemistry Letters|December 31, 2018
Discovery of potent and selective PPARα/δ dual antagonists and initial biological studiesJason D Jacintho, Christopher S Baccei, Yalda Bravo, et al.
Brain : a Journal of Neurology|December 6, 2020
Atrophy and cognitive profiles in older adults with temporal lobe epilepsy are similar to mild cognitive impairmentErik Kaestner, Anny Reyes, Austin Chen, et al.
Bioorganic & Medicinal Chemistry Letters|August 3, 2010
Addressing time-dependent CYP 3A4 inhibition observed in a novel series of substituted amino propanamide renin inhibitors, a case studyAustin Chen, Daniel Dubé, Laurence Dubé, et al.
Neurosurgery|March 26, 2026
Pathologically Confirmed Symptomatic Carotid Webs: Histopathological Features and Long-Term Surgical OutcomesMichela Rosso, Eric A Grin, Austin Chen, et al.
ACS Chemical Neuroscience|January 24, 2024
Identification and In Vivo Evaluation of Myelination Agent PIPE-3297, a Selective Kappa Opioid Receptor Agonist Devoid of β-Arrestin-2 Recruitment EfficacyThomas O Schrader, Kym I Lorrain, Didier Bagnol, et al.
Bioorganic & Medicinal Chemistry Letters|July 26, 2011
Impact of passive permeability and gut efflux transport on the oral bioavailability of novel series of piperidine-based renin inhibitors in rodentsJean-François Lévesque, Kelly Bleasby, Amandine Chefson, et al.
Biorxiv : the Preprint Server for Biology|February 27, 2026
A universal platform for simultaneous TCRα/β removal enables safer and more potent TCR therapies and autoimmune modelingGiorgia Zanetti, Mateusz Legut, Austin Chen, et al.
Bioorganic & Medicinal Chemistry Letters|February 14, 2012
3,4-Diarylpiperidines as potent renin inhibitorsPatrick Lacombe, Mélissa Arbour, Renée Aspiotis, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|May 22, 2021
Decline in Rehab Transfers Among Rehab-Eligible Stroke Patients During the COVID-19 PandemicLauren Thau, Taylor Siegal, Mark E Heslin, et al.
Bioorganic & Medicinal Chemistry Letters|March 25, 2011
The discovery and synthesis of potent zwitterionic inhibitors of reninRenee Aspiotis, Austin Chen, Elizabeth Cauchon, et al.
Pageof 6

Showing results (41-50 of 56) with videos related to

Sort By:
Pageof 6
Bioorganic & Medicinal Chemistry Letters|December 31, 2018
Discovery of potent and selective PPARα/δ dual antagonists and initial biological studiesJason D Jacintho, Christopher S Baccei, Yalda Bravo, et al.
Brain : a Journal of Neurology|December 6, 2020
Atrophy and cognitive profiles in older adults with temporal lobe epilepsy are similar to mild cognitive impairmentErik Kaestner, Anny Reyes, Austin Chen, et al.
Bioorganic & Medicinal Chemistry Letters|August 3, 2010
Addressing time-dependent CYP 3A4 inhibition observed in a novel series of substituted amino propanamide renin inhibitors, a case studyAustin Chen, Daniel Dubé, Laurence Dubé, et al.
Neurosurgery|March 26, 2026
Pathologically Confirmed Symptomatic Carotid Webs: Histopathological Features and Long-Term Surgical OutcomesMichela Rosso, Eric A Grin, Austin Chen, et al.
ACS Chemical Neuroscience|January 24, 2024
Identification and In Vivo Evaluation of Myelination Agent PIPE-3297, a Selective Kappa Opioid Receptor Agonist Devoid of β-Arrestin-2 Recruitment EfficacyThomas O Schrader, Kym I Lorrain, Didier Bagnol, et al.
Bioorganic & Medicinal Chemistry Letters|July 26, 2011
Impact of passive permeability and gut efflux transport on the oral bioavailability of novel series of piperidine-based renin inhibitors in rodentsJean-François Lévesque, Kelly Bleasby, Amandine Chefson, et al.
Biorxiv : the Preprint Server for Biology|February 27, 2026
A universal platform for simultaneous TCRα/β removal enables safer and more potent TCR therapies and autoimmune modelingGiorgia Zanetti, Mateusz Legut, Austin Chen, et al.
Bioorganic & Medicinal Chemistry Letters|February 14, 2012
3,4-Diarylpiperidines as potent renin inhibitorsPatrick Lacombe, Mélissa Arbour, Renée Aspiotis, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|May 22, 2021
Decline in Rehab Transfers Among Rehab-Eligible Stroke Patients During the COVID-19 PandemicLauren Thau, Taylor Siegal, Mark E Heslin, et al.
Bioorganic & Medicinal Chemistry Letters|March 25, 2011
The discovery and synthesis of potent zwitterionic inhibitors of reninRenee Aspiotis, Austin Chen, Elizabeth Cauchon, et al.
Pageof 6